[1]

LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.

[2]

WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.

[3]

SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.

[4]

LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.

[5]

ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.

[6]

ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.

[7]

XIE Rui, GENG Zihan, BAO Lei, ZHAO Ronghua, LI Shuran, SUN Qiyue, WANG Xinwei, ZHANG Jingsheng, CUI Xiaolan, GUO Shanshan, SUN Jing. Research Progress in Pharmacological Actions, Mechanisms, Structural Modifications and Targeted Formulations of Ribavirin [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 950-955.

[8]

LIN Lu, ZHAO Anzhi, CHEN Jinhui, LI Zhongwen, HUANG Guohua, ZHONG Shilong. One Case of Delayed Hypersensitivity Reactions Caused by Cefotaxime Sodium and Sulbactam Sodium for Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 809-811.

[9]

LI Xiaobo, ZHOU Guojian, HUANG Yuling, LI Haiqiao, CHEN Tingting. One Case of Red Man Syndrome Caused by Locally-Used Low-Dose Vancomycin [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 217-220.

[10]

SUN Qiyue, GUO Shanshan, ZHAO Ronghua, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Highly pathogenic coronavirus infection and immunothrombosis: research advances [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 246-252.

[11]

ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan. The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54.

[12]

ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan. Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58.

[13]

HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong. Automatic monitoring and assessment of antibiotics-related thrombocytopenia [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.

[14]

[15]

ZHANG Qingxia, ZHOU Liujun, LI Xiaoling, WANG Yuqin. Cefoperazone/sulbactam-related medication errors in the elderly and countermeasures [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 574-578.

PDF (PC)

Knowledge